BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15048586)

  • 21. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
    Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
    Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue and perfusate pharmacokinetics of melphalan in isolated perfused rat hindlimb.
    Wu ZY; Smithers BM; Roberts MS
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1131-8. PubMed ID: 9316818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies.
    Mougenot P; Pinguet F; Fabbro M; Culine S; Poujol S; Astre C; Bressolle F
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):503-12. PubMed ID: 15007638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin.
    Van der Speeten K; Stuart OA; Mahteme H; Sugarbaker PH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):799-805. PubMed ID: 18654746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure.
    Cotte E; Colomban O; Guitton J; Tranchand B; Bakrin N; Gilly FN; Glehen O; Tod M
    J Clin Pharmacol; 2011 Jan; 51(1):9-18. PubMed ID: 20173087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.
    Lindnér P; Heath D; Howell S; Naredi P; Hafström L
    Clin Cancer Res; 1996 Feb; 2(2):311-7. PubMed ID: 9816174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.
    Cattel L; Buffa E; De Simone M; Cesana P; Novello S; Dosio F; Ceruti M
    Anticancer Res; 2001; 21(3C):2243-8. PubMed ID: 11501854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function.
    Pilati P; Mocellin S; Rossi CR; Ori C; Innocente F; Scalerta R; Ceccherini M; Da Pian PP; Nitti D; Lise M
    World J Surg; 2004 Aug; 28(8):775-81. PubMed ID: 15457357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melphalan antitumor efficacy and hepatotoxicity: the effect of variable infusion duration in the hepatic artery.
    Rothbarth J; Woutersen RA; Sparidans RW; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1098-103. PubMed ID: 12606622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemobiokinetics of sarcolysin and its peptides with glutaminic acid].
    Mironiuk TA; Korsakov MV; Reztsova VV; Kon'kov SA; Zhdanova EA; Krasnov VP; Filov VA
    Vopr Onkol; 2000; 46(5):583-7. PubMed ID: 11202192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
    BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
    Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
    Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of melphalan in isolated limb perfusion.
    Norda A; Loos U; Sastry M; Goehl J; Hohenberger W
    Cancer Chemother Pharmacol; 1999; 43(1):35-42. PubMed ID: 9923539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
    J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
    Colombo PE; Boustta M; Poujol S; Pinguet F; Rouanet P; Bressolle F; Vert M
    Eur J Pharm Sci; 2007 May; 31(1):43-52. PubMed ID: 17383164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
    Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
    Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb.
    Wu ZY; Smithers BM; Roberts MS
    Melanoma Res; 1997 Jun; 7(3):252-64. PubMed ID: 9195565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.